These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The effects of gastric acid inhibitors]. van de Ven LL Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1285. PubMed ID: 2755529 [No Abstract] [Full Text] [Related]
4. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer]. Grigor'ev PIa; Isakov VA Sov Med; 1991; (3):39-43. PubMed ID: 1909055 [No Abstract] [Full Text] [Related]
5. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states]. Bulgakov SA Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266 [No Abstract] [Full Text] [Related]
7. Controlling acid secretion: individual variation in response. Walt RP Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804 [No Abstract] [Full Text] [Related]
8. [Effect of dalargin on the level of gastric secretion]. Tepliuk SG Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):67-8. PubMed ID: 3801139 [No Abstract] [Full Text] [Related]
9. [Recent state of therapy of peptic disease]. Pavlotzky M; Eshchar J Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295 [No Abstract] [Full Text] [Related]
10. [Long-term results of the conservative treatment of patients with peptic ulcer]. Illarionov IuA; Dudnik SP; Pokhil'ko ND; Iarosh VN Vrach Delo; 1983 Jan; (1):55-6. PubMed ID: 6868500 [No Abstract] [Full Text] [Related]
11. [Holistic and individual medical treatment of gastroduodenal ulcer]. Meeroff M; Carlos Meeroff J G E N; 1988; 42(3):126-35. PubMed ID: 3152676 [No Abstract] [Full Text] [Related]
13. Pharmacologic control of gastric acid secretion in peptic ulcer. Konturek SJ Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524 [No Abstract] [Full Text] [Related]
14. Drug treatment of peptic ulcer syndrome. Fielding JF Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254 [No Abstract] [Full Text] [Related]
15. Peptic ulcer disease in children and adolescents: evolving dilemmas. Nord KS J Pediatr Gastroenterol Nutr; 1983; 2(3):397-9. PubMed ID: 6312009 [No Abstract] [Full Text] [Related]
16. [Improving the methodological approach to the treatment of peptic ulcer]. Maĭorov VM; Piatnitskaia GK; Petrova AA Sov Med; 1989; (10):82-5. PubMed ID: 2617350 [No Abstract] [Full Text] [Related]
17. [Effects of cimetidine, antacids and free diet on the pH of gastric content, in patients with peptic ulcer]. Ribeiro Tde C; Salgado JA; Castro Lde P AMB Rev Assoc Med Bras; 1981 Apr; 27(4):119-20. PubMed ID: 6974379 [No Abstract] [Full Text] [Related]
18. [Appraisal of therapeutic agents for peptic ulcer by continuous intragastric pH monitoring]. Saeki S; Tomofuji Y; Yasuda T; Mitooka H; Onoyama Y; Baba S Rinsho Byori; 1984 Oct; 32(10):1076-83. PubMed ID: 6549190 [No Abstract] [Full Text] [Related]
19. [Antagonists of the histamine H2 receptors in the stomach]. Landa L Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460 [No Abstract] [Full Text] [Related]
20. Acid suppression and ulcer healing: dichotomy, degree, and dilemma. Hunt RH Am J Gastroenterol; 1988 Sep; 83(9):964-6. PubMed ID: 2901221 [No Abstract] [Full Text] [Related] [Next] [New Search]